Literature DB >> 10393179

Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors.

S Nakashima1, K Morinaka, S Koyama, M Ikeda, M Kishida, K Okawa, A Iwamatsu, S Kishida, A Kikuchi.   

Abstract

The involvement of Ral and its downstream molecules in receptor-mediated endocytosis was examined. Expression of either RalG23V or RalS28N, which are known to be constitutively active and dominantnegative forms, respectively, in A431 cells blocked internalization of epidermal growth factor (EGF). Stable expression of RalG23V or RalS28N in CHO-IR cells also inhibited internalization of insulin. Internalization of EGF and insulin was not affected by full-length RalBP1 which is an effector protein of Ral, but was inhibited by its C-terminal region which binds directly to Ral and POB1. POB1 is a binding protein of RalBP1 and has the Eps15 homology (EH) domain. Deletion mutants of POB1 inhibited internalization of EGF and insulin. However, internalization of transferrin was unaffected by Ral, RalBP1, POB1 and their mutants. Epsin and Eps15 have been reported to be involved in the regulation of endocytosis of the receptors for EGF and transferrin. The EH domain of POB1 bound directly to Epsin and Eps15. Taken together with the observation that EGF and insulin activate Ral, these results suggest that Ral, RalBP1 and POB1 transmit the signal from the receptors to Epsin and Eps15, thereby regulating ligand-dependent receptor-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393179      PMCID: PMC1171441          DOI: 10.1093/emboj/18.13.3629

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  78 in total

1.  Regulation of Ras signaling specificity by protein kinase C.

Authors:  G Rusanescu; T Gotoh; X Tian; L A Feig
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  The endocytic protein intersectin is a major binding partner for the Ras exchange factor mSos1 in rat brain.

Authors:  X K Tong; N K Hussain; E de Heuvel; A Kurakin; E Abi-Jaoude; C C Quinn; M F Olson; R Marais; D Baranes; B K Kay; P S McPherson
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

3.  Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein.

Authors:  S Hino; S Kishida; T Michiue; A Fukui; I Sakamoto; S Takada; M Asashima; A Kikuchi
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

4.  Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.

Authors:  D O Henry; S A Moskalenko; K J Kaur; M Fu; R G Pestell; J H Camonis; M A White
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Solution structure of the epsin N-terminal homology (ENTH) domain of human epsin.

Authors:  Seizo Koshiba; Takanori Kigawa; Akira Kikuchi; Shigeyuki Yokoyama
Journal:  J Struct Funct Genomics       Date:  2002

6.  RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells.

Authors:  Michail Shipitsin; Larry A Feig
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  RalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.

Authors:  Akiyuki Takaya; Yusuke Ohba; Kazuo Kurokawa; Michiyuki Matsuda
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

8.  Ral inhibits ligand-independent Notch signaling in Drosophila.

Authors:  Bomsoo Cho; Janice A Fischer
Journal:  Small GTPases       Date:  2012-07-01

Review 9.  Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling.

Authors:  Sharad S Singhal; Sharda P Singh; Preeti Singhal; David Horne; Jyotsana Singhal; Sanjay Awasthi
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-23       Impact factor: 4.219

10.  Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex.

Authors:  Shuya Fukai; Hugo T Matern; Junutula R Jagath; Richard H Scheller; Axel T Brunger
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.